Developed as a dual amylin and calcitonin receptor agonist, cagrilintide acetate extends the therapeutic promise of amylin-based treatments. It acts on both appetite and glucose control, reducing food intake and supporting weight loss while lowering blood glucose levels. Its structure is closely related to native amylin, with enhanced receptor activity for prolonged efficacy. Cagrilintide’s impact is further amplified when combined with GLP-1 analogs like semaglutide, positioning it as a versatile tool for metabolic disease management.
Larsen, A.T., Mohamed, K.E., Sonne, N., Bredtoft, E., Andersen, F., Karsdal, M.A. and Henriksen, K. (2022). Does receptor balance matter? – Comparing the efficacies of the dual amylin and calcitonin receptor agonists cagrilintide and KBP-336 on metabolic parameters in preclinical models. Biomedicine & Pharmacotherapy. Elsevier.
Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.
For detailed information about Cagrilintide by Stealth Labs, consult with your doctor or healthcare professional.
Larsen, A.T., Mohamed, K.E., Sonne, N., Bredtoft, E., Andersen, F., Karsdal, M.A. and Henriksen, K. (2022). Does receptor balance matter? – Comparing the efficacies of the dual amylin and calcitonin receptor agonists cagrilintide and KBP-336 on metabolic parameters in preclinical models. Biomedicine & Pharmacotherapy. Elsevier.
Larsen, A.T., Mohamed, K.E., Sonne, N., Bredtoft, E., Andersen, F., Karsdal, M.A. and Henriksen, K. (2022). Does receptor balance matter? – Comparing the efficacies of the dual amylin and calcitonin receptor agonists cagrilintide and KBP-336 on metabolic parameters in preclinical models. Biomedicine & Pharmacotherapy. Elsevier.
Larsen, A.T., Mohamed, K.E., Sonne, N., Bredtoft, E., Andersen, F., Karsdal, M.A. and Henriksen, K. (2022). Does receptor balance matter? – Comparing the efficacies of the dual amylin and calcitonin receptor agonists cagrilintide and KBP-336 on metabolic parameters in preclinical models. Biomedicine & Pharmacotherapy. Elsevier.
Home
